{
  "Country": "IT",
  "PICOs": [
    {
      "Population": "Patients eligible for treatment with LUMYKRAS (sotorasib)",
      "Intervention": "New medicine under assessment",
      "Comparator": "Standard of care or alternative therapies",
      "Outcomes": "Efficacy, safety, and reimbursement status"
    },
    {
      "Population": "Patients with advanced cancer",
      "Intervention": "New medicine under assessment",
      "Comparator": "Docetaxel",
      "Outcomes": "Overall survival, progression-free survival, and quality of life"
    }
  ]
}